MiNK Therapeutics, Inc.

INKT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$14,281$1,682$3,235$4,577
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$253$329$345$411
Total Curr. Assets$14,534$2,011$3,580$4,988
Property Plant & Equip (Net)$429$473$688$733
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$429$473$688$733
Other Assets$0$0$0$0
Total Assets$14,964$2,484$4,267$5,721
Liabilities
Payables$3,693$3,315$2,661$2,728
Short-Term Debt$5,725$5,506$5,118$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,015$4,342$4,341$4,231
Total Curr. Liab.$13,434$13,164$12,120$6,960
LT Debt$0$0$0$4,925
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$15,043$14,510$13,939$13,422
Total NC Liab.$15,043$14,510$13,939$18,347
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$28,477$27,674$26,059$25,307
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$154,073-$151,186-$146,948-$144,182
AOCI-$692-$719-$662-$632
Other Equity$141,252$126,716$125,819$125,227
Total Equity-$13,513-$25,189-$21,792-$19,586
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$14,964$2,484$4,267$5,721
Net Debt-$8,556$3,824$1,883$348